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. . . if the main pur-
pose of scientific ses-
sions is to have a
profitable trade
show, then this met-
ric is met with very
large events.
It seems that report-
ing important re-
search as it impacts
clinical practice and
having educational
venues that convey
optimal ways of
treating patients,
new techniques, and
the exchange of ideas
among colleagues is
also important.
My take-home les-
son was not that
meetings should
compete to be the
biggest, but that we
should constantly
expand the quality
of the educationalDITOR’S PAGE
pril in Paris
kay, it was not April. It was May, and the chestnut blossoms were a bit past their prime, but
he choice of Paris as the venue for EuroPCR was a good one. Moving the meeting back to
aris from Barcelona resulted in a record-breaking attendance, and I have to congratulate Wil-
iam Wijns, the program chair, Jean Marco, and all of the organizers for their success. The
nterventional meeting, as with its parent meeting, the European Society of Cardiology Scien-
ific Session, is becoming the largest in the world. Of course, logistics and geography play a
reat role in the expanding number of participants, but the less-restrictive industry sponsorship
lso plays a role. For all of the European physicians, as well as physicians from countries in the
iddle East and the Asian subcontinent, travel to Paris is much easier than to the U.S. I
eard comments that the U.S. is being eclipsed by these large events and that the organiza-
ions in North America well-known for their scientific sessions should not compete with each
ther but should get together. After all, with the ACC, AHA, TCT, SCAI, and others, there
re many competing interests. But the question is: what are we competing for?
Walking the floor of the exhibits gives one clear answer. The displays were extensive (after
ll, there are about 22 approved stents in Europe and everyone wants their say) and the space
as usually filled with delegates. One industry representative said that having a concentrated
ew days with so many of their customers made great business sense. I am sure this is correct,
nd if the main purpose of scientific sessions is to have a profitable trade show, then this
etric is met with very large events.
But is this the prime purpose of a “scientific session?” It seems that reporting important
esearch as it impacts clinical practice and having educational venues that convey optimal ways
f treating patients, new techniques, and the exchange of ideas among colleagues is also important.
o not get me wrong—the organizers of the Paris meeting did an admirable job of providing
pportunities for all of these educational goals. The theme of the meeting, “Think Globally,
ct Locally,” although not original with medicine, reflected the application of group evidence
pplied at the personalized level. Cases, either live or pre-recorded, seemed less hurried, giving
ime for questions of not only “how” but “why” to be answered. Concepts presented ranged
rom clinical decision-making through technical aspects to the anticipated short- and long-
erm outcomes. The delegates obviously found sessions dealing with expert and audience
nteraction especially appealing since rooms dealing with these subjects were overflowing. A
opic of great interest was the experience with transcutaneous aortic valve implantation, a
echnique that has been applied in Europe in over 10,000 cases. Many have had early
xperience in the technique, but the sharing of problems encountered seemed equally valid
hether they were presented by audience participants, the designated speakers, or panel
embers. Here, the interaction of surgeons and cardiologists was particularly refreshing.
This event was not without problems, such as over-subscribed sessions with attendees unable
o get into popular presentation rooms. This is a problem that also plagues the ACC scientific
ession from time-to-time when the organizers are unable to predict the popularity of certain
opics.
My take-home lesson was not that meetings should compete to be the biggest, but that we
hould constantly expand the quality of the educational experience. The EuroPCR meeting has
rown from a small experiment in Toulouse started by Jean Marco. Likewise, the European
ociety of Cardiology Scientific Session, modeled after the ACC and the AHA sessions, has
ecome perhaps the largest cardiology meeting.
experience.
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789One of the things I have learned from interviewing
eaders of several national societies is that cost containment
n medicine is not limited to any one country, but is of great
nterest for all economies of the world. As the economic and
egulatory considerations become globalized, meetings of
onstantly increasing size may no longer be possible, but this
hould not deter our competition for quality, which will
nhance the value of these events for all cardiovascular
hysicians and our patients.
When I was president of the American College of
ardiology we hosted Dr. Lars Ryden, then president of
he ESC, at Heart House to incorporate ideas into the
evelopment of the ESC Heart House and their organization. she staff of the ACC was an important resource for the
SC development. We should celebrate the dynamic
xpansion of this educational mission. I believe we can all
ontinue to learn from each other, not how to be bigger,
ut how to be better.
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